Common TitlePOSITRON
Official Title Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
Phase Phase III
ClinicalTrials.gov NCT01542788
Treatments
Sofosbuvir

Sofosbuvir
Tradename:SovaldiOther Names:SOFClass:FDA-ApprovedFunding
IndustryGilead Sciences